Henry Prince

Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

Reinhard Dummer, Henry M Prince, Sean Whittaker, Steven M Horwitz, Youn H Kim, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Herbert Eradat, Lauren Pinter-Brown, Jose A Sanches, Pablo L Ortiz-Romero, Oleg E Akilov, Larisa Geskin, Auris Huen, Jan Walewski, Yinghui Wang, Julie Lisano, Akshara Richhariya, et al.

Journal article  |  2020  |  European Journal of Cancer

BACKGROUND: Brentuximab vedotin was approved for adult patients with CD30-expressing cutaneous T-cell lymphoma treated with prior ..

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study).

P Quaglino, HM Prince, R Cowan, M Vermeer, L Papadavid, M Bagot, O Servitjie, E Berti, E Guenova, R Stadler, C Querfeld, AM Busschots, E Hodak, A Patsatsi, J Sanches, M Maule, J Yoo, M Kevin, P Fava, S Ribero, et al.

Journal article  |  2020  |  British Journal of Dermatology

BACKGROUND: The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a prospective analysis of an int..

Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis

Meletios A Dimopoulos, Xavier Leleu, Philippe Moreau, Paul G Richardson, Anna Marina Liberati, Simon J Harrison, H Miles Prince, Enrique M Ocio, Sylvie Assadourian, Frank Campana, Laure Malinge, Dorothee Semiond, Helgi van de Velde, Kwee Yong

Journal article  |  2020  |  Leukemia

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic

Pietro Di Ciaccio, Georgia McCaughan, Judith Trotman, Phoebe Joy Ho, Chan Y Cheah, Shane Gangatharan, Joel Wight, Matthew Ku, Hang Quach, Robin Gasiorowski, Mark N Polizzotto, Henry Miles Prince, Stephen Mulligan, Constantine S Tam, Gareth Gregory, Greg Hapgood, Andrew Spencer, Michael Dickinson, Maya Latimer, Anna Johnston, et al.

Journal article  |  2020  |  Internal Medicine Journal

The COVID-19 pandemic poses a unique challenge to the care of patients with haematological malignancies. Viral pneumonia is known ..

Primary cutaneous anaplastic large cell lymphoma and evolving clinical practice: 26 years of skin lesions with locoregional progression to systemic disease

Crystal Gao, Sean Harrop, Carrie Van der Weyden, Chris McCormack, H Miles Prince

Journal article  |  2020  |  Leukemia & Lymphoma

The importance of differentiating between Mycosis Fungoides with CD30 positive large cell transformation and Mycosis Fungoides with co-existent primary cutaneous Anaplastic Large Cell Lymphoma.

Crystal Gao, Christopher J McCormack, Carrie van der Weyden, Robert Twigger, Odette Buelens, Stephen Lade, Christine Khoo, Belinda A Campbell, Michelle Goh, Penny McKelvie, H Miles Prince

Journal article  |  2020  |  Journal of the American Academy of Dermatology

Patient-reported outcome measures in multiple myeloma: Real-time reporting to improve care (My-PROMPT) - a pilot randomized controlled trial

Elizabeth M Moore, Tracy A King, Erica M Wood, Rasa Ruseckaite, Daniela Klarica, Andrew Spencer, P Joy Ho, Hang Quach, H Miles Prince, Zoe K McQuilten

Journal article  |  2020  |  American Journal of Hematology

Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy

Michael P MacManus, Rodney J Hicks, Mathias Bressel, Belinda A Campbell, Andrew Wirth, Gail Ryan, H Miles Prince, Max Wolf, Rachel Brown, John F Seymour

Journal article  |  2020  |  Cancers

Advanced-stage follicular lymphoma (FL) is generally considered incurable with conventional systemic therapies, but historic serie..

A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patients

Joanne Brooker, John Julian, Jeremy Millar, H Miles Prince, Melita Kenealy, Kirsten Herbert, Annette Graham, Robin Smith, David Kissane, Karen Taylor, Mark Frydenberg, Ian Porter, Jane Fletcher, Ian Haines, Sue Burney

Journal article  |  2020  |  Palliative and Supportive Care

AbstractObjectivesPsychosocial interventions that mitigate psychosocial distress in cancer patients are important. The primary aim..

A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Isatuximab, Pomalidomide, and Low-Dose Dexamethasone Versus Pomalidomide and Low-Dose Dexamethasone in Patients with Relapsed / Multiple Myeloma Refractory (RRMM)

Dietger Niederwieser, Paul Richardson, Michel Attal, Vincent Rajkumar, Jesus San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Dimopoulosu, Jeffrey Shang-Yi Huan, Jiri Minarik, Michele Cavo, Sandrine Mace, H Miles Prince, Kathryn P Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, et al.

Conference Proceedings  |  2020  |  ONCOLOGY RESEARCH AND TREATMENT

A practical guide to laboratory investigations at diagnosis and follow up in Waldenstrom macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group

M Gohar Maqbool, Constantine S Tam, Ian M Morison, David Simpson, Peter Mollee, Hans Schneider, Henry Chan, Surender Juneja, Yasmin Harvey, Lakshmi Nath, Pravin Hissaria, H Miles Prince, Helen Wordsworth, Stephen Opat, Dipti Talaulikar

Journal article  |  2020  |  Pathology

A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and Sezary syndrome

T Papps, C McCormack, O Buelens, C Van der Weyden, R Twigger, BA Campbell, M Dickinson, HM Prince

Journal article  |  2020  |  British Journal of Dermatology

Diagnosis of West Nile virus encephalitis in a returned traveller

Naomi CA Whyler, Jasmine C Teng, David J Brewster, Ruth Chin, Ian Cox, Julian Druce, Henry M Prince, David A Sheffield, Eugene Teh, Vineet Sarode

Journal article  |  2019  |  Medical Journal of Australia

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Michel Attal, Paul G Richardson, S Vincent Rajkumar, Jesus San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Jeffrey Shang-Yi Huang, Jiri Minarik, Michele Cavo, H Miles Prince, Sandrine Mace, Kathryn P Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C Anderson

Journal article  |  2019  |  The Lancet

Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab

Wenwen Zhang, Henry Miles Prince, Katrina Reardon

Journal article  |  2019  |  BMJ Case Reports

Statin-induced immune-mediated necrotising myopathy (IMNM) is a rare but increasingly recognised myositis. Many cases have positiv..

Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides

Belinda A Campbell, Gail Ryan, Christopher McCormack, Eleanor Tangas, Mathias Bressel, Robert Twigger, Odette Buelens, Carrie van der Weyden, H Miles Prince

Journal article  |  2019  |  Cancers

Mycosis fungoides (MF) and Sezary syndrome (SS) are multi-relapsing, morbid, cutaneous T-cell lymphomas. Optimal treatment sequenc..

A Novel Application of [F-18]Fluorothymidine-PET ([F-18]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" Radiotherapy

Belinda A Campbell, Michael S Hofman, H Miles Prince

Journal article  |  2019  |  Clinical Nuclear Medicine

F-Fluorothymidine-positron emission tomography with CT fusion ([F]FLT-PET/CT) offers a unique and non-invasive method for three-di..

Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sezary syndrome

Crystal Gao, Christopher McCormack, Carrie van der Weyden, Michelle S Goh, Belinda A Campbell, Robert Twigger, Odette Buelens, Simon J Harrison, Christine Khoo, Stephen Lade, H Miles Prince

Journal article  |  2019  |  Blood

Extracorporeal photopheresis (ECP) has demonstrated therapeutic benefit in patients with Sézary syndrome (SS) and erythrodermic my..

Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care (My-PROMPT) - a pilot randomised controlled trial

Elizabeth Moore, Tracy King, P Joy Ho, Daniela Klarica, H Miles Prince, Hang Quach, Rasa Ruseckaite, Alicia Snowden, Andrew Spencer, Erica Wood, Zoe McQuilten

Conference Proceedings  |  2019  |  Clinical Lymphoma Myeloma and Leukemia

Effect of isatuximab plus pomalidomide/dexamethasone on renal impairment in relapsed/refractory multiple myeloma: ICARIA-MM study subgroup analysis

Meletios A Dimopoulos, Xavier Leleu, Philippe Moreau, Michel Attal, Paul G Richardson, Anna Marina Liberati, Simon J Harrison, H Miles Prince, Enrique M Ocio, Sylvie Assadourian, Frank Campana, Laure Malinge, Helgi van de Velde, Kwee Yong

Conference Proceedings  |  2019  |  Clinical Lymphoma Myeloma and Leukemia

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients

JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, O Servitje, E Berti, P Ortiz-Romero, R Stadler, A Patsatsi, R Knobler, E Guenova, F Child, S Whittaker, V Nikolaou, C Tomasini, I Amitay, H Prag Naveh, C Ram-Wolff, et al.

Journal article  |  2019  |  British Journal of Dermatology

BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Lymphoma Internation..

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

Noemi Horvath, Andrew Spencer, Melita Kenealy, Douglas Joshua, Philip J Campbell, Je-Jung Lee, Jian Hou, Lugui Qiu, Anna Kalff, Tiffany Khong, Anil Londhe, Sarah Siggins, Maximiliano van Kooten Losio, Michael Eisbacher, H Miles Prince

Journal article  |  2019  |  Leukemia & Lymphoma

The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment

Nicole Wong Doo, Victoria M White, Kara Martin, Julie K Bassett, H Miles Prince, Simon J Harrison, Michael Jefford, Ingrid Winship, Jeremy L Millar, Roger L Milne, John F Seymour, Graham G Giles

Journal article  |  2019  |  Cancers

INTRODUCTION: Diffuse large B cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma for which a cure is usually the ..

Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma

Robert J Ellis, Victoria M White, Damien M Bolton, Michael D Coory, Ian D Davis, Ross S Francis, Graham G Giles, Glenda C Gobe, David JT Marco, Rachel E Neale, Simon T Wood, Susan J Jordan, Graham Giles, Victoria White, Michael Coory, Jeremy Millar, Damien Bolton, Ian Davis, Ingrid Winship, Ian Roos, et al.

Journal article  |  2019  |  Clinical Genitourinary Cancer

A phase III randomized, open label, multicenter study comparing isatuximab, pomalidomide, and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM).

Paul G Richardson, Michel Attal, S Vincent Rajkumar, Jesus San Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Jeffrey SY Huang, Jiri Minarik, Michele Cavo, H Miles Prince, Sandrine Mace, Kathryn Penkus Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth Carl Anderson

Conference Proceedings  |  2019  |  JOURNAL OF CLINICAL ONCOLOGY

Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of POLLUX based on cytogenetic risk.

Jonathan L Kaufman, Meletios A Dimopoulos, Merav Leiba, James Morton, P Joy Ho, Kihyun Kim, Philippe Moreau, Heather J Sutherland, Shinsuke Iida, Jin Seok Kim, H Miles Prince, Albert Oriol Rocafiguera, Nizar J Bahlis, Ajai Chari, Herve Avet-Loiseau, Christopher Chiu, David Soong, Jon Ukropec, Ming Qi, Jesus San Miguel

Conference Proceedings  |  2019  |  JOURNAL OF CLINICAL ONCOLOGY

DIAGNOSIS OF WEST NILE VIRUS ENCEPHALITIS IN AN IMMUNOCOMPROMISED RETURNED TRAVELLER

Naomi CA Whyler, Jasmine C Teng, David Brewster, Ruth Chin, Ian Cox, Julian Druce, Miles Prince, David A Sheffield, Eugene Teh, Vineet Sarode

Conference Proceedings  |  2019  |  INTERNAL MEDICINE JOURNAL

Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease

JJ Scarisbrick, P Quaglino, HM Prince, YH Kim, R Willemze

Journal article  |  2019  |  British Journal of Dermatology

The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants

Mark Magnusson, Kenneth Beath, Rodney Cooter, Michelle Locke, H Miles Prince, Elisabeth Elder, Anand K Deva

Journal article  |  2019  |  Plastic and Reconstructive Surgery

A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)

Andrew Wirth, H Miles Prince, Daniel Roos, John Gibson, Peter O'Brien, Diana Zannino, Bereha Khodr, Janey M Stone, Sidney Davis, Mark Hertzberg

Journal article  |  2019  |  International Journal of Radiation Oncology*Biology*Physics

Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS

Gareth P Gregory, Michael Dickinson, Costas K Yannakou, Jonathan Wong, Piers Blombery, Greg Corboy, Lev Kats, Tim ME Crozier, Beena Kumar, H Miles Prince, Stephen S Opat, Jake Shortt

Journal article  |  2019  |  HemaSphere

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma

Greg Hapgood, Janey M Stone, Diana Zannino, Anup George, Paula Marlton, Henry Miles Prince, Chi-Hung Hui, Ian Prosser, Ian D Lewis, Kenneth Bradstock, John F Seymour

Journal article  |  2019  |  Leukemia & Lymphoma

Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma

Piers Blombery, Ella R Thompson, H Miles Prince

Journal article  |  2019  |  Plastic and Reconstructive Surgery

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell lymphoproliferative disorder occurring in pat..

Psoriasis and cancer. An Australian/New Zealand narrative

Marius Rademaker, Diana M Rubel, Karen Agnew, Megan Andrews, Katherine Sarah Armour, Christopher Baker, Peter Foley, Kurt Gebauer, Michelle SY Goh, Monisha Gupta, Gillian Marshman, H Miles Prince, John Sullivan

Journal article  |  2019  |  Australasian Journal of Dermatology

Brentuximab vedotin in T-cell lymphoma

Carrie Van der Weyden, Michael Dickinson, James Whisstock, H Miles Prince

Journal article  |  2019  |  Expert Review of Hematology

Rare T-Cell Subtypes.

C van der Weyden, C McCormack, S Lade, RW Johnstone, HM Prince

Book Chapter  |  2019  |  Cancer Treatment and Research

There are a number of rare T-cell lymphoma subtypes that may be encountered in clinical practice. In recent years, improved immuno..

FDG-PET/CT findings, the vital clue to rare diagnosis of herpes simplex virus lymphadenitis simulating Richter transformation

Abby P Douglas, Mohammad Atarod, H Miles Prince

Journal article  |  2019  |  Pathology

Brentuximab vedotin (BV) versus physician's choice (PC) of methotrexate or bexarotene in adult patients with previously treated CD30-positive cutaneous T-cell lymphoma (CTCL; mycosis fungoides [MF] or primary cutaneous anaplastic large cell lymphoma [pcALCL]): final time to next therapy (TTNT) results from the phase 3 ALCANZA study

Julia Scarisbrick, Steven M Horwitz, H Miles Prince, Sean Whittaker, Madeleine Duvic, Youn H Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg Akilov, Larisa Geskin, Jose Sanches, Pablo Ortiz-Romero, Julie Lisano, Lisa Brown, Veronica Bunn, Meredith Little, Reinhard Dummer

Conference Proceedings  |  2019  |  EUROPEAN JOURNAL OF CANCER

A retrospective analysis of patients with co-existent mycosis fungoides and primary cutaneous anaplastic large cell lymphoma from the Australian Cutaneous Lymphoma Network database

C Gao, C McCormack, C van der Weyden, R Twigger, O Buelens, S Lade, C Khoo, BA Campbell, M Goh, P McKelvie, HM Prince

Conference Proceedings  |  2019  |  European Journal of Cancer

A review of 65 patients with mycosis fungoides/Sezary syndrome treated with extracorporeal photopheresis: our experience at Peter MacCallum Cancer Centre

C Gao, C McCormack, C van der Weyden, MS Goh, BA Campbell, R Twigger, O Buelens, SJ Harrison, C Khoo, S Lade, HM Prince

Conference Proceedings  |  2019  |  European Journal of Cancer

Breast Implant-Associated Anaplastic Large Cell Lymphoma

P Rastogi, AK Deva, H Miles Prince

Journal article  |  2018  |  Current Hematologic Malignancy Reports

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX

Meletios A Dimopoulos, Jesus San-Miguel, Andrew Belch, Darrell White, Lotfi Benboubker, Gordon Cook, Merav Leiba, James Morton, P Joy Ho, Kihyun Kim, Naoki Takezako, Philippe Moreau, Jonathan L Kaufman, Heather J Sutherland, Marc Lalancette, Hila Magen, Shinsuke Iida, Jin Seok Kim, H Miles Prince, Tara Cochrane, et al.

Journal article  |  2018  |  Haematologica

Superior Clinical Benefit of Brentuximab Vedotin in Mycosis Fungoides Versus Physician's Choice Irrespective of CD30 Level or Large Cell Transformation Status in the Phase 3 ALCANZA Study

Youn H Kim, H Miles Prince, Sean Whittaker, Steven M Horwitz, Madeleine Duvic, Oliver Bechter, Jose A Sanches, Rudolf Stadler, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Herbert Eradat, Lauren C Pinter-Brown, Pablo L Ortiz-Romero, Oleg E Akilov, Judith Trotman, Kerry Taylor, Michael Weichenthal, Jan Walewski, et al.

Conference Proceedings  |  2018  |  Blood

Germline TIM-3 Mutations Characterize Sub-Cutaneous Panniculitis T-Cell Lymphomas with Hemophagocytic Lymphohistiocytic Syndrome

Dong-Anh Khuong-Quang, Tenzin Gayden, Fernando Sepulveda, Jonathan Pratt, Elvis Valera, Alexandrine Garrigue, Susan Kelso, Frank Sicheri, Leonie Mikael, Nancy Hamel, Andrea Bajic, Rola Dali, Dzana Dervovic, Daniel Schramek, Frederic Guerin, Mikko Taipale, Hamid Nikbakht, Jacek Majewski, Despina Moshous, Janie Charlebois, et al.

Conference Proceedings  |  2018  |  Blood

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.

Piers Blombery, Ella Thompson, Georgina L Ryland, Rachel Joyce, David J Byrne, Christine Khoo, Stephen Lade, Mark Hertzberg, Greg Hapgood, Paula Marlton, Anand Deva, Geoffrey Lindeman, Stephen Fox, David Westerman, Miles Prince

Journal article  |  2018  |  Oncotarget

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare form of T-cell lymphoma that occurs after implantati..

A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy

Peter KK Wong, Hanish Bagga, Claire Barrett, Geoff Chong, Patrick Hanrahan, Teja Kodali, Mona Marabani, H Miles Prince, John Riordan, Phillip Swarbrick, Ray White, Laurel Young

Journal article  |  2018  |  Current Rheumatology Reports

Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay

Piers A Blombery, Georgina L Ryland, John Markham, Jerick Guinto, Meaghan Wall, Michelle McBean, Kate Jones, Ella R Thompson, Daniel L Cameron, Anthony T Papenfuss, Miles H Prince, Michael Dickinson, David Alan Westerman

Journal article  |  2018  |  British Journal of Haematology

Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing

Georgina L Ryland, Kate Jones, Melody Chin, John Markham, Elle Aydogan, Yamuna Kankanige, Marisa Caruso, Jerick Guinto, Michael Dickinson, H Miles Prince, Kwee Yong, Piers Blombery

Journal article  |  2018  |  Journal of Clinical Pathology

Integrating novel systemic therapies for the treatment of mycosis fungoides and Sezary syndrome

H Miles Prince, Christiane Querfeld

Journal article  |  2018  |  Best Practice & Research Clinical Haematology

Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sezary syndrome and those with more extensive skin involvement

Kevin Molloy, Felicity Evison, Chenjing Peng, Emmanuella Guenova, Richard Cowan, Annemie Busschots, Sherida H Woei-A-Jin, An Bervoets, Esther Hauben, Marie Beylot-Barry, Constanze Jonak, Robert Knobler, Stefanie Pokert, Evangelina Papadavid, Liisa Vakeva, Rubeta Matin, Andrew Bates, Teresa Estrach, Miles Prince, Robert Twigger, et al.

Conference Proceedings  |  2018  |  European Journal of Cancer

Treatment of advanced Mycosis Fungoides and Sezary Syndrome, including emerging new therapies

H Miles Prince

Conference Proceedings  |  2018  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

Molecular landscape of cutaneous T Cell lymphoma (including ALCL associated with breast implants)

H Miles Prince

Conference Proceedings  |  2018  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy

Lucy C Fox, Costas K Yannakou, Georgina Ryland, Stephen Lade, Michael Dickinson, Belinda A Campbell, Henry Miles Prince

Journal article  |  2018  |  International Journal of Molecular Sciences

Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sezary Syndrome

Louise Photiou, Carrie van der Weyden, Christopher McCormack, H Miles Prince

Journal article  |  2018  |  Current Oncology Reports

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma

Nicholas A Gherardin, Liyen Loh, Lorenztino Admojo, Alexander J Davenport, Kelden Richardson, Amy Rogers, Phillip K Darcy, Misty R Jenkins, H Miles Prince, Simon J Harrison, Hang Quach, David P Fairlie, Katherine Kedzierska, James McCluskey, Adam P Uldrich, Paul J Neeson, David S Ritchie, Dale I Godfrey

Journal article  |  2018  |  SCIENTIFIC REPORTS

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

AJ Davenport, RS Cross, KA Watson, Y Liao, W Shi, HM Prince, PA Beavis, JA Trapani, MH Kershaw, DS Ritchie, PK Darcy, PJ Neeson, MR Jenkins

Journal article  |  2018  |  Proceedings of the National Academy of Sciences

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma

Hang Quach, Simon Benson, Helen Haysom, Anne-Marie Wilkes, Nicole Zacher, Merrole Cole-Sinclair, Henry Miles Prince, Peter Mollee, Andrew Spencer, Phoebe Joy Ho, Simon J Harrison, Cindy Lee, Bradley Augustson, James Daly

Journal article  |  2018  |  Internal Medicine Journal

Brentuximab vedotin: Targeting CD30 as standard in CTCL

HM Prince, A Gautam, YH Kim

Journal article  |  2018  |  Oncotarget

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

Carrie Van Der Weyden, Martine Bagot, Paul Neeson, Phil K Darcy, H Miles Prince

Journal article  |  2018  |  Expert Opinion on Investigational Drugs

BGB-3111 in Combination with Obinutuzumab in Patients with Chronic Lymphocytic Leukemia and Follicular Lymphoma

Constantine S Tam, Quach Hang, Andrew Nicol, Xavier Badoux, Hannah Rose, H Miles Prince, Michael F Leahy, Richard Eek, Nicholas Wickham, Sushrut S Patil, Jane Huang, Xiaoping Zhang, Lai Wang, Eric Hedrick, William Novotny, Ian W Flinn

Conference Proceedings  |  2017  |  BLOOD

Blueprint unknown: a case for multidisciplinary management of advanced penile mycosis fungoides

Jonathan S O'Brien, Todd Manning, Marlon Perera, H Miles Prince, Nathan Lawrentschuk

Journal article  |  2017  |  Canadian Journal of Urology

The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers

Devesh Oberoi, Victoria M White, John F Seymour, H Miles Prince, Simon Harrison, Michael Jefford, Ingrid Winship, David Hill, Damien Bolton, Anne Kay, Jeremy Millar, Nicole Wong Doo, Graham Giles

Journal article  |  2017  |  Supportive Care in Cancer

Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study

Victoria White, David JT Marco, Damien Bolton, Ian Douglas Davis, Michael Jefford, David Hill, Henry Miles Prince, Jeremy L Millar, Ingrid M Winship, Michael Coory, Graham G Giles

Journal article  |  2017  |  BJU International

Distress and unmet needs during treatment and quality of life in early cancer survivorship: A longitudinal study of haematological cancer patients

Devesh V Oberoi, Victoria M White, John F Seymour, H Miles Prince, Simon Harrison, Michael Jefford, Ingrid Winship, David J Hill, Damien Bolton, Jeremy Millar, Nicole Wong Doo, Anne Kay, Graham Giles

Journal article  |  2017  |  European Journal of Haematology

Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk

Anna Loch-Wilkinson, Kenneth J Beath, Robert John William Knight, William Louis Fick Wessels, Mark Magnusson, Tim Papadopoulos, Tony Connell, Julian Lofts, Michelle Locke, Ingrid Hopper, Rodney Cooter, Karen Vickery, Preeti Avinash Joshi, H Miles Prince, Anand K Deva

Journal article  |  2017  |  Plastic and Reconstructive Surgery

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

P Quaglino, M Maule, HM Prince, P Porcu, S Horwitz, M Duvic, R Talpur, M Vermeer, M Bagot, J Guitart, E Papadavid, JA Sanches, E Hodak, M Sugaya, E Berti, P Ortiz-Romero, N Pimpinelli, O Servitje, A Pileri, PL Zinzani, et al.

Journal article  |  2017  |  Annals of Oncology

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial (vol 9, 22, 2016)

Francine Foss, Steven Horwitz, Barbara Pro, H Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier

Journal article  |  2017  |  Journal of Hematology & Oncology

Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions

CA van der Weyden, SA Pileri, AL Feldman, J Whisstock, HM Prince

Journal article  |  2017  |  Blood Cancer Journal

Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome

Thomas A Rasmussen, James McMahon, J Judy Chang, Jori Symons, Michael Roche, Ashanti Dantanarayana, Afam Okoye, Bonnie Hiener, Sarah Palmer, Wen Shi Lee, Stephen J Kent, Carrie Van der Weyden, H Miles Prince, Paul U Cameron, Sharon R Lewin

Journal article  |  2017  |  AIDS

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H Miles Prince, Youn H Kim, Steven M Horwitz, Reinhard Dummer, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Jose A Sanches, Pablo L Ortiz-Romero, Oleg E Akilov, Larisa Geskin, Judith Trotman, Kerry Taylor, Stephane Dalle, Michael Weichenthal, Jan Walewski, David Fisher, Brigitte Dreno, Rudolf Stadler, et al.

Journal article  |  2017  |  The Lancet

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Oi Lin Lee, Noemi Horvath, Cindy Lee, Doug Joshua, Joy Ho, Jeff Szer, Hang Quach, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W Roberts, Dipti Talaulikar, Ross Brown, Bradley Augustson, Silvia Ling, Wilfrid Jaksic, John Gibson, Anna Kalff, Anna Johnston, Akash Kalro, et al.

Journal article  |  2017  |  Internal Medicine Journal

Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of Lymphoma

Piers Blombery, Henry M Prince, John F Seymour

Journal article  |  2017  |  JNCI: Journal of the National Cancer Institute

The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period

Devesh Oberoi, Victoria White, John Seymour, H Miles Prince, Simon Harrison, Michael Jefford, Ingrid Winship, David Hill, Damien Bolton, Anne Kay, Jeremy Millar, Nicole Wong Doo, Graham Giles

Journal article  |  2017  |  Journal of Cancer Survivorship

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting

Clare Y Slaney, Bianca von Scheidt, Alexander J Davenport, Paul A Beavis, Jennifer A Westwood, Sherly Mardiana, David C Tscharke, Sarah Ellis, H Miles Prince, Joseph A Trapani, Ricky W Johnstone, Mark J Smyth, Michele W Teng, Aesha Ali, Zhiya Yu, Steven A Rosenberg, Nicholas P Restifo, Paul Neeson, Phillip K Darcy, Michael H Kershaw

Journal article  |  2017  |  Clinical Cancer Research

No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

Talia M Mota, Thomas A Rasmussen, Ajantha Rhodes, Surekha Tennakoon, Ashanti Dantanarayana, Fiona Wightman, Michelle Hagenauer, Janine Roney, Tim Spelman, Damian FJ Purcell, James McMahon, Jennifer F Hoy, H Miles Prince, Julian H Elliott, Sharon R Lewin

Journal article  |  2017  |  AIDS

Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study

Hang Quach, Liam Fernyhough, Ross Henderson, Gillian Corbett, Bart Baker, Peter Browett, Hilary Blacklock, Cecily Forsyth, Craig Underhill, Paul Cannell, Judith Trotman, Annette Neylon, Simon Harrison, Emma Link, Arlene Swern, Linda Cowan, Meletios A Dimopoulos, H Miles Prince

Journal article  |  2017  |  British Journal of Haematology

Rituximab-induced Crohn's disease

Poornima Varma, Julianne Falconer, Ahmad Aga, H Miles Prince, Stephen Pianko

Journal article  |  2017  |  Scandinavian Journal of Gastroenterology

Treatment of patients with Waldenstrom macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Dipti Talaulikar, Constantine S Tam, Douglas Joshua, Joy Phoebe Ho, Jeff Szer, Hang Quach, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W Roberts, Noemi Horvath, Cindy Lee, Andrew Zannettino, Ross Brown, Bradley Augustson, Wilfrid Jaksic, John Gibson, Anna Kalff, Anna Johnston, Judith Trotman, et al.

Journal article  |  2017  |  Internal Medicine Journal

Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement

Kah-Lok Chan, Carrie van der Weyden, Christine Khoo, Stephen Lade, Piers Blombery, David Westerman, Amit Khot, Brian Melo, Ricky W Johnstone, H Miles Prince, Michael Dickinson

Journal article  |  2017  |  Leukemia & Lymphoma

Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials

Andrei Shustov, Bertrand Coiffier, Steven Horwitz, Lubomir Sokol, Barbara Pro, Julie Wolfson, Barbara Balser, Robin Eisch, Leslie Popplewell, H Miles Prince, Steven L Allen, Richard Piekarz, Susan Bates

Journal article  |  2017  |  Leukemia & Lymphoma

Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma

Francine Foss, Barbara Pro, H Miles Prince, Lubomir Sokol, Dolores Caballero, Steven Horwitz, Bertrand Coiffier

Journal article  |  2017  |  Cancer Medicine

Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation

Kah-Lok Chan, Julie Lokan, Constantine S Tam, Thomas Eliot Lew, H Miles Prince

Journal article  |  2017  |  Leukemia & Lymphoma

How do tumor cells respond to HDAC inhibition?

Andrea Newbold, Katrina J Falkenberg, H Miles Prince, Ricky W Johnstone

Journal article  |  2016  |  The FEBS Journal

Caregivers' information needs and their 'experiences of care' during treatment are associated with elevated anxiety and depression: a cross-sectional study of the caregivers of renal cancer survivors

Devesh V Oberoi, Vicki White, Michael Jefford, Graham G Giles, Damien Bolton, Ian Davis, Ingrid Winship, H Miles Prince, Jeremy Millar, Simon Harrison, Anne Kay, David Hill

Journal article  |  2016  |  Supportive Care in Cancer

Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma

Rachel E Cooke, Nicholas A Gherardin, Simon J Harrison, Hang Quach, Dale I Godfrey, Miles Prince, Rachel Koldej, David S Ritchie

Journal article  |  2016  |  JOURNAL OF TRANSLATIONAL MEDICINE

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma

Piers Blombery, Ella R Thompson, Kate Jones, Gisela Mir Arnau, Stephen Lade, John F Markham, Jason Li, Anand Deva, Ricky W Johnstone, Amit Khot, H Miles Prince, David Westerman

Journal article  |  2016  |  Haematologica

Mycosis fungoides and Sezary syndrome: Current challenges in assessment, management and prognostic markers

Charlotte FM Hughes, Kate Newland, Christopher McCormack, Stephen Lade, H Miles Prince

Journal article  |  2016  |  Australasian Journal of Dermatology

Commentary on: Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma

H Miles Prince, Ricky Johnstone

Journal article  |  2016  |  Aesthetic Surgery Journal

How I treat mycosis fungoides and Sezary syndrome

Sean Whittaker, Richard Hoppe, H Miles Prince

Journal article  |  2016  |  Blood

A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer

Carmen SM Yong, Liza B John, Christel Devaud, Miles H Prince, Ricky W Johnstone, Joseph A Trapani, Phillip K Darcy, Michael H Kershaw

Journal article  |  2016  |  ONCOTARGET

Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma

Honghua Hu, Khalid Johani, Ahmad Almatroudi, Karen Vickery, Bruce Van Natta, Marshall E Kadin, Garry Brody, Mark Clemens, Chan Yoon Cheah, Stephen Lade, Preeti Avinash Joshi, H Miles Prince, Anand K Deva

Journal article  |  2016  |  Plastic and Reconstructive Surgery

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

Francine Foss, Steven Horwitz, Barbara Pro, H Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier

Journal article  |  2016  |  Journal of Hematology & Oncology

High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from "orphan drug" to a standard-of-care?

Carrie van der Weyden, H Miles Prince

Journal article  |  2016  |  Leukemia & Lymphoma

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy

Thomas E Lew, Chan Y Cheah, Dennis A Carney, H Miles Prince, Max Wolf, Ali Bazargan, E Henry Januszewicz, Robin Filshie, David Westerman, John F Seymour, Constantine S Tam

Journal article  |  2016  |  Leukemia & Lymphoma

Update and new approaches in the treatment of Castleman disease

Kah-Lok Chan, Stephen Lade, H Miles Prince, Simon J Harrison

Journal article  |  2016  |  Journal of Blood Medicine

Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms

Nicole Wong Doo, Enes Makalic, JiHoon E Joo, Claire M Vajdic, Daniel F Schmidt, Ee Ming Wong, Chol-Hee Jung, Gianluca Severi, Daniel J Park, Jessica Chung, Laura Baglietto, Henry Miles Prince, John F Seymour, Constantine Tam, John L Hopper, Dallas R English, Roger L Milne, Simon J Harrison, Melissa C Southey, Graham G Giles

Journal article  |  2016  |  Epigenomics

Prevention of thromboembolism in myeloma: expanding the tool-box of assays to predict the risk?

Kate L Burbury, Michael Dickinson, David A Westerman, H Miles Prince

Journal article  |  2015  |  Leukemia & Lymphoma

CD30 As a Target for the Treatment of Cutaneous T-Cell Lymphoma

H Miles Prince

Journal article  |  2015  |  Journal of Clinical Oncology

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia J Scarisbrick, H Miles Prince, Maarten H Vermeer, Pietro Quaglino, Steven Horwitz, Pierluigi Porcu, Rudolf Stadler, Gary S Wood, Marie Beylot-Barry, Anne Pham-Ledard, Francine Foss, Michael Girardi, Martine Bagot, Laurence Michel, Maxime Battistella, Joan Guitart, Timothy M Kuzel, Maria Estela Martinez-Escala, Teresa Estrach, Evangelia Papadavid, et al.

Journal article  |  2015  |  Journal of Clinical Oncology

Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two cases

Kate M Newland, Christopher J McCormack, H Miles Prince, Stephen Lade

Journal article  |  2015  |  Australasian Journal of Dermatology

Use of romidepsin for the treatment of mycosis fungoides and Sezary syndrome - role of romidepsin in the current therapeutic landscape and implications for future practice

Carrie van der Weyden, Michael Dickinson, Susan E Bates, Henry Miles Prince

Journal article  |  2015  |  Expert Opinion on Orphan Drugs

Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma"

Simon J Harrison, Hang Quach, Andrew Spencer, H Miles Prince

Journal article  |  2015  |  Haematologica

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data

Susan E Bates, Robin Eisch, Alexander Ling, Douglas Rosing, Maria Turner, Stefania Pittaluga, H Miles Prince, Mark H Kirschbaum, Steven L Allen, Jasmine Zain, Larisa J Geskin, David Joske, Leslie Popplewell, Edward W Cowen, Elaine S Jaffe, Jean Nichols, Sally Kennedy, Seth M Steinberg, David J Liewehr, Louise C Showe, et al.

Journal article  |  2015  |  British Journal of Haematology

Errata: Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia (Blood (2011) 117, 13 (3658-3668))

MJ Bishton, SJ Harrison, BP Martin

Journal article  |  2015  |  Blood

Inflammatory pseudotumor of the spleen

Georgia McMahon, Kirsty Rady, Henry Miles Prince

Journal article  |  2015  |  Hematology Reports

Isolated splenic inflammatory pseudotumors (IPT) are extremely rare, typically benign, inflammatory lesions with varied clinical p..

The efficacy of methotrexate for lymphomatoid papulosis

Kate M Newland, Christopher J McCormack, Robert Twigger, Odette Buelens, Charlotte FM Hughes, Stephen Lade, Michael Dickinson, Lee Mei Yap, Gail Ryan, H Miles Prince

Journal article  |  2015  |  Journal of the American Academy of Dermatology

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit

Simon J Harrison, Hang Quach, Emma Link, Huaibao Feng, Joanne Dean, Michael Copeman, Helgi Van de Velde, Anthony Schwarer, Bartrum Baker, Andrew Spencer, John Catalano, Philip Campbell, Bradley Augustson, Ken Romeril, Henry Miles Prince

Journal article  |  2015  |  American Journal of Hematology

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

Alexander J Davenport, Misty R Jenkins, Ryan S Cross, Carmen S Yong, H Miles Prince, David S Ritchie, Joseph A Trapani, Michael H Kershaw, Phillip K Darcy, Paul J Neeson

Journal article  |  2015  |  CANCER IMMUNOLOGY RESEARCH

Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

N Weber, P Mollee, B Augustson, R Brown, L Catley, J Gibson, S Harrison, PJ Ho, N Horvath, W Jaksic, D Joshua, H Quach, AW Roberts, A Spencer, J Szer, D Talaulikar, B To, A Zannettino, HM Prince

Journal article  |  2015  |  Internal Medicine Journal

Utility of (18)fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma

S Horwitz, B Coiffier, F Foss, HM Prince, L Sokol, M Greenwood, D Caballero, F Morschhauser, L Pinter-Brown, SP Iyer, A Shustov, J Nichols, J Balser, B Balser, B Pro

Journal article  |  2015  |  Annals of Oncology

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group

H Quach, D Joshua, J Ho, J Szer, A Spencer, S Harrison, P Mollee, AW Roberts, N Horvath, D Talaulikar, B To, A Zannettino, R Brown, L Catley, B Augustson, W Jaksic, J Gibson, HM Prince

Journal article  |  2015  |  Internal Medicine Journal

A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma

Jason A Trubiano, Anupkumar George, Jennifer Barnett, Mahendra Siwan, Alexander Heriot, H Miles Prince, Monica A Slavin, Benjamin W Teh

Journal article  |  2015  |  Leukemia & Lymphoma

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib

Paul J Neeson, Andy K Hsu, Yin R Chen, Heloise M Halse, Joanna Loh, Reece Cordy, Kate Fielding, Joanne Davis, Josh Noske, Alex J Davenport, Camilla A Lindqvist-Gigg, Robin Humphreys, Tsin Tai, H Miles Prince, Joseph A Trapani, Mark J Smyth, David S Ritchie

Journal article  |  2015  |  OncoImmunology

Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report

Louise Kostos, Kate Burbury, Gaurav Srivastava, H Miles Prince

Journal article  |  2015  |  Platelets

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

H Quach, D Joshua, J Ho, J Szer, A Spencer, SJ Harrison, P Mollee, AW Roberts, N Horvath, D Talulikar, B To, A Zannettino, R Brown, L Catley, B Augustson, W Jaksic, J Gibson, HM Prince

Journal article  |  2015  |  Internal Medicine Journal

The utility and limitations of F-18-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review

Chan Y Cheah, Michael S Hofman, John F Seymour, David S Ritchie, Michael Dickinson, Andrew Wirth, H Miles Prince, Max Wolf, Elchanan H Januszcewicz, Dennis A Carney, Kirsten E Herbert, Simon J Harrison, Kate L Burbury, Constantine S Tam

Journal article  |  2015  |  Leukemia & Lymphoma

Inflammatory pseudotumor of the spleen

Georgia McMahon, Kirsty Rady, Henry Miles Prince

Journal article  |  2015  |  HEMATOLOGY REPORTS

Lack of durable disease control with chemotherapy for mycosis fungoides and Sezary syndrome: a comparative study of systemic therapy

Charlotte FM Hughes, Amit Khot, Christopher McCormack, Stephen Lade, David A Westerman, Robert Twigger, Odette Buelens, Kate Newland, Constantine Tam, Michael Dickinson, Gail Ryan, David Ritchie, Colin Wood, H Miles Prince

Journal article  |  2015  |  Blood

CAR-T cells are serial killers

Alexander J Davenport, Misty R Jenkins, David S Ritchie, H Miles Prince, Joseph A Trapani, Michael H Kershaw, Phillip K Darcy, Paul J Neeson

Journal article  |  2015  |  OncoImmunology

Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation

J Sasadeusz, HM Prince, A Schwarer, J Szer, A Stork, HL Bock, M Povey, O Nicholson, BL Innis

Journal article  |  2014  |  Transplant Infectious Disease

Thalidomide and prednisolone versus prednisolone alone as consolidation therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the ALLG MM6 multicentre, open-label, randomised phase 3 study

Anna Kalff, Nola Kennedy, Angela Smiley, H Miles Prince, Andrew W Roberts, Kenneth Bradstock, Richard De Abreu Loureno, Chris Frampton, Andrew Spencer

Journal article  |  2014  |  The Lancet Haematology

Identifying mutant pathways in the histiocytoses

H Miles Prince

Journal article  |  2014  |  Blood

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

Julian H Elliott, Fiona Wightman, Ajantha Solomon, Khader Ghneim, Jeffrey Ahlers, Mark J Cameron, Miranda Z Smith, Tim Spelman, James McMahon, Pushparaj Velayudham, Gregor Brown, Janine Roney, Jo Watson, Miles H Prince, Jennifer F Hoy, Nicolas Chomont, Remi Fromentin, Francesco A Procopio, Joumana Zeidan, Sarah Palmer, et al.

Journal article  |  2014  |  PLOS PATHOGENS

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

CY Cheah, KE Herbert, K O'Rourke, GA Kennedy, A George, PL Fedele, M Gilbertson, SY Tan, DS Ritchie, SS Opat, HM Prince, M Dickinson, K Burbury, M Wolf, EH Januszewicz, CS Tam, DA Westerman, DA Carney, SJ Harrison, JF Seymour

Journal article  |  2014  |  British Journal of Cancer

Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression

Y Oki, D Buglio, J Zhang, Y Ying, S Zhou, A Sureda, D Ben-Yehuda, PL Zinzani, HM Prince, SJ Harrison, M Kirschbaum, PB Johnston, A Shen, B von Tresckow, A Younes

Journal article  |  2014  |  Blood Cancer Journal

Adult Orbital Xanthogranuloma Successfully Treated with Rituximab

Khami Satchi, Alan A McNab, Timothy Godfrey, H Miles Prince

Journal article  |  2014  |  Ophthalmology

The Choice of Multiple Myeloma Induction Therapy Affects the Frequency and Severity of Oral Mucositis After Melphalan-Based Autologous Stem Cell Transplantation

Shaun Fleming, Simon J Harrison, Piers Blombery, Trish Joyce, Kerrie Stokes, John F Seymour, H Miles Prince, David Ritchie

Journal article  |  2014  |  Clinical Lymphoma Myeloma and Leukemia

Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial

KE Herbert, L Demosthenous, G Wiesner, E Link, DA Westerman, N Came, DS Ritchie, S Harrison, JF Seymour, HM Prince

Journal article  |  2014  |  Bone Marrow Transplantation

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy

Chan Y Cheah, Michael Dickinson, Michael S Hofman, Anupkumar George, David S Ritchie, H Miles Prince, David Westerman, Simon J Harrison, Kate Burbury, Max Wolf, Henry Januszewicz, Kirsten E Herbert, Dennis A Carney, Constantine Tam, John F Seymour

Journal article  |  2014  |  ANNALS OF HEMATOLOGY

Emerging drugs for T-cell lymphoma

Michael Dickinson, Henry Miles Prince

Journal article  |  2014  |  Expert Opinion On Emerging Drugs

Denileukin diftitox for the treatment of cutaneous T-cell lymphoma

H Miles Prince, Kate M Newland

Journal article  |  2014  |  Expert Opinion on Orphan Drugs

Prognostic factors, prognostic indices and staging in mycosis fungoides and Sezary syndrome: where are we now?

JJ Scarisbrick, YH Kim, SJ Whittaker, GS Wood, MH Vermeer, HM Prince, P Quaglino

Journal article  |  2014  |  British Journal of Dermatology

IgG4-related disease with cutaneous manifestations treated with rituximab: Case report and literature review

Chris Jalilian, H Miles Prince, Chris McCormack, Stephen Lade, Chan Y Cheah

Journal article  |  2014  |  Australasian Journal of Dermatology

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Simon J Harrison, Andy K Hsu, Paul Neeson, Anas Younes, Anna Sureda, Andreas Engert, H Miles Prince, Martha Li, Paula Savage, Roberto Bugarini, Denise Williams, Margaret Squier, David S Ritchie

Journal article  |  2014  |  Leukemia & Lymphoma

Challenges and outcomes of a randomized study of early nutrition support during autologous stem-cell transplantation

N Kiss, JF Seymour, HM Prince, G Dutu

Journal article  |  2014  |  CURRENT ONCOLOGY

Myeloma and pregnancy: strange bedfellows?

Amit S Khot, H Miles Prince, Simon J Harrison, John F Seymour

Journal article  |  2014  |  Leukemia & Lymphoma

Prognostic impact of monocyte count at presentation in mantle cell lymphoma

Anupkumar George, Henry Miles Prince, Jeff Szer, Max Wolf, Elchanan H Januszewicz, John F Seymour, David S Ritchie

Journal article  |  2014  |  British Journal of Haematology

Exacerbation of lymphomatoid papulosis during rituximab therapy

Olivia McCurdy, Chris McCormack, David Ritchie, H Miles Prince

Journal article  |  2014  |  Australasian Journal of Dermatology

Low Uptake of Upfront Autologous Transplantation for Myeloma in a Jurisdiction With Universal Health Care Coverage: A Population-Based Patterns of Care Study in Australia

Nicole Wong Doo, Michael Coory, Victoria White, Simon J Harrison, H Miles Prince, Jeremy L Millar, Margaret Dimech, Graham G Giles

Journal article  |  2014  |  Clinical Lymphoma, Myeloma & Leukemia

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

Bertrand Coiffier, Barbara Pro, H Miles Prince, Francine Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Franck Morschhauser, Martin Wilhelm, Lauren Pinter-Brown, Swaminathan Padmanabhan Iyer, Andrei Shustov, Tina Nielsen, Jean Nichols, Julie Wolfson, Barbara Balser, Steven Horwitz

Journal article  |  2014  |  Journal of Hematology & Oncology

Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients

Roberto N Miranda, Tariq N Aladily, H Miles Prince, Rashmi Kanagal-Shamanna, Daphne de Jong, Luis E Fayad, Mitual B Amin, Nisreen Haideri, Govind Bhagat, Glen S Brooks, David A Shifrin, Dennis P O'Malley, Chan Y Cheah, Carlos E Bacchi, Gabriela Gualco, Shiyong Li, John A Keech, Ephram P Hochberg, Matthew J Carty, Summer E Hanson, et al.

Journal article  |  2014  |  Journal of Clinical Oncology

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.

Francine Foss, Bertrand Coiffier, Steven Horwitz, Barbara Pro, H Miles Prince, Lubomir Sokol, Matthew Greenwood, Adam Lerner, Dolores Caballero, Eugeniusz Baran, Ellen Kim, Jean Nichols, Barbara Balser, Julie Wolfson, Sean Whittaker

Journal article  |  2014  |  Biomarker Research

BACKGROUND: Histone deacetylase inhibitor romidepsin has demonstrated durable clinical responses and tolerability in patients with..

Are we close to a prognostic index for cutaneous T cell lymphoma?

H Miles Prince

Journal article  |  2014  |  Leukemia & Lymphoma

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

AC Chan, P Neeson, E Leeansyah, K Tainton, H Quach, HM Prince, SJ Harrison, DI Godfrey, D Ritchie, SP Berzins

Journal article  |  2014  |  CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Romidepsin for cutaneous T-cell lymphoma

H Miles Prince, Michael Dickinson, Amit Khot

Journal article  |  2013  |  Future Oncology

Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

David S Ritchie, Paul J Neeson, Amit Khot, Stefan Peinert, Tsin Tai, Kellie Tainton, Karen Chen, Mandy Shin, Dominic M Wall, Dirk Hoenemann, Peter Gambell, David A Westerman, Javier Haurat, Jennifer A Westwood, Andrew M Scott, Lucy Kravets, Michael Dickinson, Joseph A Trapani, Mark J Smyth, Phillip K Darcy, et al.

Journal article  |  2013  |  Molecular Therapy

Panobinostat in lymphoid and myeloid malignancies

Amit Khot, Michael Dickinson, H Miles Prince

Journal article  |  2013  |  Expert Opinion on Investigational Drugs

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review of the Literature and Mini-Meta Analysis

Philip A Thompson, H Miles Prince

Journal article  |  2013  |  Hematology

A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors

Sunil Sharma, Joachim Beck, Monica Mita, Sofia Paul, Margaret M Woo, Margaret Squier, Brian Gadbaw, H Miles Prince

Journal article  |  2013  |  INVESTIGATIONAL NEW DRUGS

Duration of Response in Cutaneous T-Cell Lymphoma Patients Treated With Denileukin Diftitox: Results From 3 Phase III Studies

Madeleine Duvic, Larisa Geskin, H Miles Prince

Journal article  |  2013  |  Clinical Lymphoma, Myeloma & Leukemia

A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive disease

BW Teh, AS Khot, SJ Harrison, HM Prince, MA Slavin

Journal article  |  2013  |  Transplant Infectious Disease

Romidepsin for peripheral T-cell lymphoma

Amit Khot, Michael Dickinson, H Miles Prince

Journal article  |  2013  |  Expert Review of Hematology

Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies

DJ DeAngelo, A Spencer, KN Bhalla, HM Prince, T Fischer, T Kindler, FJ Giles, JW Scott, K Parker, A Liu, M Woo, P Atadja, KK Mishra, OG Ottmann

Journal article  |  2013  |  Leukemia

Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy

CY Cheah, MS Hofman, M Dickinson, A Wirth, D Westerman, SJ Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, HM Prince, DA Carney, DS Ritchie, RJ Hicks, JF Seymour

Journal article  |  2013  |  BRITISH JOURNAL OF CANCER

Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma

Nicole Wong Doo, Philip A Thompson, H Miles Prince, John F Seymour, David Ritchie, Kerrie Stokes, Kate Burbury, Max Wolf, Trish Joyce, Simon J Harrison

Journal article  |  2013  |  Leukemia and Lymphoma

Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptide

Mark J Bishton, Elizabeth E Gardiner, Simon J Harrison, H Miles Prince, Ricky W Johnstone

Journal article  |  2013  |  Thrombosis Research

Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells

KE Herbert, P Gambell, EK Link, A Mouminoglu, DM Wall, SJ Harrison, DS Ritchie, JF Seymour, HM Prince

Journal article  |  2013  |  Bone Marrow Transplantation

Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma

Madeleine Duvic, Ann G Martin, Elise A Olsen, David P Fivenson, H Miles Prince

Journal article  |  2013  |  Leukemia and Lymphoma

A Risk-Adapted Protocol for Delayed Administration of Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation

Amit Khot, Michael Dickinson, Kerrie Stokes, Simon Harrison, Kate Burbury, Shaun Fleming, Dominic Wall, Peter Gambell, H Miles Prince, John F Seymour, David Ritchie

Journal article  |  2013  |  Clinical Lymphoma & Myeloma

Panobinostat activity in both bexarotene-exposed and -naive patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial

Madeleine Duvic, Reinhard Dummer, Juergen C Becker, Nicolas Poulalhon, Pablo Ortiz Romero, Maria Grazia Bernengo, Celeste Lebbe, Chalid Assaf, Margaret Squier, Denise Williams, Miriam Marshood, Feng Tai, H Miles Prince

Journal article  |  2013  |  European Journal of Cancer

Current epigenetic therapy for T-cell lymphoma

M Dickinson, C Cheah, HM Prince

Book Chapter  |  2013

Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sezary syndrome

H Miles Prince, Ann G Martin, Elise A Olsen, David P Fivenson, Madeleine Duvic

Journal article  |  2013  |  Leukemia and Lymphoma

Emergence of central nervous system myeloma in the era of novel agents

Shane A Gangatharan, Dennis A Carney, H Miles Prince, Max M Wolf, E Henry Januszewicz, David S Ritchie, Simon J Harrison

Journal article  |  2012  |  Hematological Oncology

Erdheim-Chester Disease Harboring the BRAF V600E Mutation

Piers Blombery, Stephen Q Wong, Stephen Lade, H Miles Prince

Journal article  |  2012  |  Journal of Clinical Oncology

Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sezary syndrome receiving placebo

H Miles Prince, Madeleine Duvic, Ann Martin, Wolfram Sterry, Chalid Assaf, David J Straus

Journal article  |  2012  |  Journal of the American Academy of Dermatology

A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax (R))

Simon J Harrison, Mark Bishton, Susan E Bates, Steven Grant, Richard L Piekarz, Ricky W Johnstone, Yun Dai, Becki Lee, Maria E Araujo, H Miles Prince

Journal article  |  2012  |  Epigenomics

Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials

H Miles Prince

Journal article  |  2012  |  Leukemia and Lymphoma

Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals

Shuo Li, Stuart Roberts, Magdalena Plebanski, Maelenn Gouillou, Tim Spelman, Philippe Latour, David Jackson, Lorena Brown, Rosemary L Sparrow, H Miles Prince, Derek Hart, Bruce E Loveland, Eric J Gowans

Journal article  |  2012  |  PLOS ONE

Romidepsin for Cutaneous T-cell Lymphoma

H Miles Prince, Michael Dickinson

Journal article  |  2012  |  Clinical Cancer Research

Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study

Anas Younes, Anna Sureda, Dina Ben-Yehuda, Pier Luigi Zinzani, Tee-Chuan Ong, H Miles Prince, Simon J Harrison, Mark Kirschbaum, Patrick Johnston, Jennifer Gallagher, Christophe Le Corre, Angela Shen, Andreas Engert

Journal article  |  2012  |  Journal of Clinical Oncology

A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis

Peter Mollee, Campbell Tiley, Ilona Cunningham, John Moore, H Miles Prince, Paul Cannell, Steve Gibbons, Jill Tate, Sanjoy Paul, Helen Mar Fan, Devinder S Gill

Journal article  |  2012  |  British Journal of Haematology

Peripheral Blood CD34( ) Cell Enumeration as a Predictor of Apheresis Yield: An Analysis of More Than 1,000 Collections

Peter Gambell, Kirsten Herbert, Michael Dickinson, Kerrie Stokes, Mathias Bressel, Dominic Wall, Simon Harrison, H Miles Prince

Journal article  |  2012  |  Biology of Blood and Marrow Transplantation

Fludarabine and a histone deacetylase inhibitor - Strange bedfellows

H Miles Prince

Journal article  |  2012  |  Leukemia Research

Anaplastic Large Cell Lymphoma and Breast Implants: Five Australian Cases

Kim O Taylor, Howard R Webster, H Miles Prince

Journal article  |  2012  |  Plastic and Reconstructive Surgery

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Bertrand Coiffier, Barbara Pro, H Miles Prince, Francine Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Peter Borchmann, Franck Morschhauser, Martin Wilhelm, Lauren Pinter-Brown, Swaminathan Padmanabhan, Andrei Shustov, Jean Nichols, Susan Carroll, John Balser, Barbara Balser, Steven Horwitz

Journal article  |  2012  |  Journal of Clinical Oncology

The use of methotrexate in dermatology: a review

Sarah Shen, Tim O'Brien, Lei Mee Yap, H Miles Prince, Christopher J McCormack

Journal article  |  2012  |  Australasian Journal of Dermatology

Response Dexamethasone dose alters expression of NK activating receptors in vivo

Andy Hsu, Hang Quach, Tsin Tai, H Miles Prince, Simon J Harrison, Joseph A Trapani, Mark J Smyth, Paul J Neeson, David S Ritchie

Journal article  |  2011  |  Blood

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma

Simon J Harrison, Hang Quach, Emma Link, John F Seymour, David S Ritchie, Sam Ruell, Joanne Dean, Henry Januszewicz, Ricky Johnstone, Paul Neeson, Michael Dickinson, Jean Nichols, H Miles Prince

Journal article  |  2011  |  Blood

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Werner Kempf, Katrin Pfaltz, Maarten H Vermeer, Antonio Cozzio, Pablo L Ortiz-Romero, Martine Bagot, Elise Olsen, Youn H Kim, Reinhard Dummer, Nicola Pimpinelli, Sean Whittaker, Emmilia Hodak, Lorenzo Cerroni, Emilio Berti, Steve Horwitz, H Miles Prince, Joan Guitart, Teresa Estrach, Jose A Sanches, Madeleine Duvic, et al.

Journal article  |  2011  |  Blood

Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications

Piers Blombery, H Miles Prince, Leon J Worth, Jo Main, Melissa Yang, Erica M Wood, David A Westerman

Journal article  |  2011  |  Annals of Hematology

Cytogenetic response is not a prerequisite for clinical response in patients with myelodysplastic syndromes treated with azacitidine

Shane A Gangatharan, Dennis A Carney, Lynda J Campbell, H Miles Prince, Melita K Kenealy, John F Seymour

Journal article  |  2011  |  European Journal of Haematology

MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi)

Kate L Burbury, Mark J Bishton, Ricky W Johnstone, Michael J Dickinson, Jeffrey Szer, H Miles Prince

Journal article  |  2011  |  Annals of Hematology

Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A Olsen, Sean Whittaker, Youn H Kim, Madeleine Duvic, H Miles Prince, Stuart R Lessin, Gary S Wood, Rein Willemze, Marie-France Demierre, Nicola Pimpinelli, Maria Grazia Bernengo, Pablo L Ortiz-Romero, Martine Bagot, Teresa Estrach, Joan Guitart, Robert Knobler, Jose Antonio Sanches, Keiji Iwatsuki, Makoto Sugaya, Reinhard Dummer, et al.

Journal article  |  2011  |  Journal of Clinical Oncology

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Richard L Piekarz, Robin Frye, H Miles Prince, Mark H Kirschbaum, Jasmine Zain, Steven L Allen, Elaine S Jaffe, Alexander Ling, Maria Turner, Cody J Peer, William D Figg, Seth M Steinberg, Sonali Smith, David Joske, Ian Lewis, Laura Hutchins, Michael Craig, A Tito Fojo, John J Wright, Susan E Bates

Journal article  |  2011  |  Blood

Managing multiple myeloma in the elderly: are we making progress?

Hang Quach, H Miles Prince, Andrew Spencer

Journal article  |  2011  |  Expert Review of Hematology

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

PA Thompson, HM Prince, JF Seymour, D Ritchie, K Stokes, K Burbury, M Wolf, S Peinert, T Joyce, SJ Harrison

Journal article  |  2011  |  Bone Marrow Transplantation

Lymphoproliferative disorders Part 2 - Chronic lymphocytic leukaemia and follicular lymphoma

S Kamel, JF Seymour, HM Prince

Journal article  |  2011  |  Australian Doctor

Lymphoproliferative disorders Part 1 - Aggressive non-Hodgkin lymphoma and Hodgkin lymphoma

PA Blombery, A Wirth, HM Prince

Journal article  |  2011  |  Australian Doctor

Breast Implant-Associated, ALK-Negative, T-Cell, Anaplastic, Large-Cell Lymphoma: Establishment and Characterization of a Model Cell Line (TLBR-1) for This Newly Emerging Clinical Entity

Melissa G Lechner, Stephen Lade, Daniel J Liebertz, H Miles Prince, Garry S Brody, Howard R Webster, Alan L Epstein

Journal article  |  2011  |  Cancer

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia

Mark J Bishton, Simon J Harrison, Benjamin P Martin, Nicole McLaughlin, Chloe James, Emma C Josefsson, Katya J Henley, Benjamin T Kile, H Miles Prince, Ricky W Johnstone

Journal article  |  2011  |  Blood

New drug therapies in peripheral T-cell lymphoma

Rebecca A Howman, H Miles Prince

Journal article  |  2011  |  Expert Review of Anticancer Therapy

Rituximab-Induced Immunodysregulatory Ileocolitis in a Patient With Follicular Lymphoma

Piers Blombery, H Miles Prince, Michele Levinson, Stephen Pianko, Ellen Maxwell, Prithi Bhathal

Journal article  |  2011  |  Journal of Clinical Oncology

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

Andy K Hsu, Hang Quach, Tsin Tai, H Miles Prince, Simon J Harrison, Joseph A Trapani, Mark J Smyth, Paul Neeson, David S Ritchie

Journal article  |  2011  |  Blood

A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment

Senthil Lingaratnam, Leon J Worth, Monica A Slavin, Craig A Bennett, Suzanne W Kirsa, John F Seymour, Andrew Dalton, Bogda Koczwara, H Miles Prince, Mary O'Reilly, Linda Mileshkin, Jeff Szer, Karin A Thursky

Journal article  |  2011  |  Australian Health Review

An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009

S Lingaratnam, MA Slavin, L Mileshkin, B Solomon, K Burbury, JF Seymour, R Sharma, B Koczwara, SW Kirsa, ID Davis, M Prince, J Szer, C Underhill, O Morrissey, KA Thursky

Journal article  |  2011  |  Internal Medicine Journal

Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011

S Lingaratnam, MA Slavin, B Koczwara, JF Seymour, J Szer, C Underhill, M Prince, L Mileshkin, M O'Reilly, SW Kirsa, CA Bennett, ID Davis, O Morrissey, KA Thursky

Journal article  |  2011  |  Internal Medicine Journal

Alloreactive natural killer cells in hematopoietic stem cell transplantation

Hollie J Pegram, David S Ritchie, Mark J Smyth, Andres Wiernik, H Miles Prince, Phillip K Darcy, Michael H Kershaw

Journal article  |  2011  |  Leukemia Research

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy

DA Carney, DA Westerman, CS Tam, A Milner, HM Prince, M Kenealy, M Wolf, EH Januszewicz, D Ritchie, N Came, JF Seymour

Journal article  |  2010  |  Leukemia

Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect

Michael Dickinson, Ricky W Johnstone, H Miles Prince

Journal article  |  2010  |  Investigational New Drugs

The deacetylase inhibitors - here to stay!

H Miles Prince

Journal article  |  2010  |  Investigational New Drugs

Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity

Philip A Thompson, Stephen Lade, Howard Webster, Gail Ryan, H Miles Prince

Journal article  |  2010  |  Haematologica

Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenstrom macroglobulinemia

Stefan Peinert, Constantine S Tam, H Miles Prince, John Scarlett, Max M Wolf, E Henry Januszewicz, David Westerman, John F Seymour

Journal article  |  2010  |  Leukemia and Lymphoma

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

Eric J Gowans, Stuart Roberts, Kathryn Jones, Irene Dinatale, Philippe A Latour, Brendan Chua, Emily MY Eriksson, Ruth Chin, Shuo Li, Dominic M Wall, Rosemary L Sparrow, Jude Moloney, Maureen Loudovaris, Rosemary Ffrench, H Miles Prince, Derek Hart, Weng Zeng, Joseph Torresi, Lorena E Brown, David C Jackson

Journal article  |  2010  |  Journal of Hepatology

Ex vivo culture of chimeric antigen receptor T cells generates functional CD8( ) T cells with effector and central memory-like phenotype

P Neeson, A Shin, KM Tainton, P Guru, HM Prince, SJ Harrison, S Peinert, MJ Smyth, JA Trapani, MH Kershaw, PK Darcy, DS Ritchie

Journal article  |  2010  |  Gene Therapy

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies.

Mark J Bishton, Ricky W Johnstone, Michael Dickinson, Simon Harrison, H Miles Prince

Journal article  |  2010  |  Pharmaceuticals

Histone deacetylase inhibitors (HDACi) can induce hyperacetylation of both histone and non-histone target resulting in epigenetic ..

Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy

Michael Dickinson, Rosemary Hoyt, Andrew W Roberts, Andrew Grigg, John F Seymour, H Miles Prince, Jeff Szer, David Ritchie

Journal article  |  2010  |  British Journal of Haematology

Extra-nasal NK/T cell lymphoma masquerading as renal infarction

Mun Sem Liew, Andrea M Chan, Stuart Galloway, Giulio Comin, Brendan Flaim, H Miles Prince, Hang Quach

Journal article  |  2010  |  Leukemia and Lymphoma

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation

PJ Shaughnessy, BJ Bolwell, K van Besien, M Mistrik, A Grigg, A Dodds, HM Prince, S Durrant, O Ilhan, D Parenti, J Gallo, F Foss, J Apperley, M-J Zhang, MM Horowitz, S Abhyankar

Journal article  |  2010  |  Bone Marrow Transplantation

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen

S Peinert, HM Prince, PM Guru, MH Kershaw, MJ Smyth, JA Trapani, P Gambell, S Harrison, AM Scott, FE Smyth, PK Darcy, K Tainton, P Neeson, DS Ritchie, D Hoenemann

Journal article  |  2010  |  Gene Therapy

Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma

H Miles Prince, Madeleine Duvic, Ann Martin, Wolfram Sterry, Chalid Assaf, Yijun Sun, David Straus, Mark Acosta, Andres Negro-Vilar

Journal article  |  2010  |  Journal of Clinical Oncology

Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma

Andrew P Grigg, Janey Stone, Alvin D Milner, Anthony P Schwarer, Max Wolf, H Miles Prince, John Seymour, Devinder Gill, David Ellis, John Bashford

Journal article  |  2010  |  Leukemia and Lymphoma

Light chain deposition disease presenting as massive hepatomegaly

Shriram Vaidia Nath, Modisha Peiris, Mark J Bishton, Ellen Maxwell, H Miles Prince

Journal article  |  2010  |  Pathology

Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient

Alastair B Law, Gail Ryan, Stephen Lade, H Miles Prince

Journal article  |  2010  |  International Journal of Hematology

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients

AC Chan, P Neeson, E Leeansyah, K Tainton, H Quach, HM Prince, DI Godfrey, D Ritchie, SP Berzins

Journal article  |  2010  |  Leukemia

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy

S Gill, D Carney, D Ritchie, M Wolf, D Westerman, HM Prince, H Januszewicz, JF Seymour

Journal article  |  2010  |  Annals of Oncology

The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution

Kirsten E Herbert, H Miles Prince, David S Ritchie, John F Seymour

Journal article  |  2010  |  Expert Opinion on Biological Therapy

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

H Quach, D Ritchie, AK Stewart, P Neeson, S Harrison, MJ Smyth, HM Prince

Journal article  |  2010  |  Leukemia

How I treat mycosis fungoides and Sezary syndrome

H Miles Prince, Sean Whittaker, Richard T Hoppe

Journal article  |  2009  |  Blood

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard L Piekarz, Robin Frye, Maria Turner, John J Wright, Steven L Allen, Mark H Kirschbaum, Jasmine Zain, H Miles Prince, John P Leonard, Larisa J Geskin, Craig Reeder, David Joske, William D Figg, Erin R Gardner, Seth M Steinberg, Elaine S Jaffe, Maryalice Stetler-Stevenson, Stephen Lade, A Tito Fojo, Susan E Bates

Journal article  |  2009  |  Journal of Clinical Oncology

Thalidomide Maintenance in Multiple Myeloma: Certainties and Controversies Reply

Andrew Spencer, H Miles Prince, Andrew W Roberts

Journal article  |  2009  |  Journal of Clinical Oncology

Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future

Stefan Peinert, Michael H Kershaw, H Miles Prince

Journal article  |  2009  |  Immunotherapy

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report

David Ritchie, Richard L Piekarz, Piers Blombery, Laszlo J Karai, Stefania Pittaluga, Elaine S Jaffe, Mark Raffeld, John E Janik, H Miles Prince, Susan E Bates

Journal article  |  2009  |  Haematologica

Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma

Michael Dickinson, David Ritchie, Daniel J DeAngelo, Andrew Spencer, Oliver G Ottmann, Thomas Fischer, Kapil N Bhalla, Angela Liu, Katie Parker, Jeffrey W Scott, Mark Bishton, H Miles Prince

Journal article  |  2009  |  British Journal of Haematology

Mantle cell lymphoma with central nervous system involvement: frequency and clinical features

Saar Gill, Kirsten E Herbert, H Miles Prince, Max M Wolf, Andrew Wirth, Gail Ryan, Dennis A Carney, David S Ritchie, John M Davies, John F Seymour

Journal article  |  2009  |  British Journal of Haematology

Panobinostat (LBH589): A novel pan-deacetylase inhibitor with activity in T cell lymphoma

HM Prince, M Bishton

Conference Proceedings  |  2009  |  Haematologica Meeting Reports

Fludarabine combinations for patients with advanced marginal zone lymphomas - best treatment option or too toxic?

Stefan Peinert, Dennis Carney, H Miles Prince, E Henry Januszewicz, John F Seymour

Journal article  |  2009  |  British Journal of Haematology

Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab

Violet Kieu, Timothy O'Brien, Lee-Mei Yap, Christopher Baker, Peter Foley, Graham Mason, H Miles Prince, Christopher McCormack

Journal article  |  2009  |  Australasian Journal of Dermatology

IMPACT OF F-18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY BEFORE AND AFTER DEFINITIVE RADIATION THERAPY IN PATIENTS WITH APPARENTLY SOLITARY PLASMACYTOMA

Paul J Kim, Rodney J Hicks, Andrew Wirth, Gail Ryan, John F Seymour, H Miles Prince, Michael P Mac Manus

Journal article  |  2009  |  International Journal of Radiation: Oncology - Biology - Physics

Clinical Studies of Histone Deacetylase Inhibitors

H Miles Prince, Mark J Bishton, Simon J Harrison

Journal article  |  2009  |  Clinical Cancer Research

Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors

H Miles Prince, Mark J Bishton, Ricky W Johnstone

Journal article  |  2009  |  Future Oncology

Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma

Edward A Stadtmauer, Donna M Weber, Ruben Niesvizky, Andrew Belch, Miles H Prince, Jesus F San Miguel, Thierry Facon, Marta Olesnyckyj, Zhinuan Yu, Jerome B Zeldis, Robert D Knight, Meletios A Dimopoulos

Journal article  |  2009  |  European Journal of Haematology

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034)

H Miles Prince, Dirk Hoenemann, Andrew Spencer, David A Rizzieri, Edward A Stadtmauer, Andrew W Roberts, Nizar Bahlis, Guido Tricot, Bill Bell, Douglas J DeMarini, A Benjamin Suttle, Katherine L Baker, Lini N Pandite

Journal article  |  2009  |  BLOOD

Safety and efficacy results from an international Expanded Access Programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patients

H Quach, N Horvath, P Cannell, JR Mikhael, BE Butcher, HM Prince

Journal article  |  2009  |  Internal Medicine Journal

Successful treatment of lymphomatoid papulosis with photodynamic therapy

Michelle Rodrigues, Christopher McCormack, Lee-Mei Yap, H Miles Prince, Hugh Roberts, Richard Williams, Peter Foley

Journal article  |  2009  |  Australasian Journal of Dermatology

Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment

M Dickinson, HM Prince, S Kirsa, A Zannettino, SDJ Gibbs, L Mileshkin, J O'Grady, JF Seymour, J Szer, N Horvath, DE Joshua

Journal article  |  2009  |  INTERNAL MEDICINE JOURNAL

Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure

Andrew Spencer, H Miles Prince, Andrew W Roberts, Ian W Prosser, Kenneth F Bradstock, Luke Coyle, Devinder S Gill, Noemi Horvath, John Reynolds, Nola Kennedy

Journal article  |  2009  |  Journal of Clinical Oncology

The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum

Jennifer A Westwood, William K Murray, Melanie Trivett, Nicole M Haynes, Benjamin Solomon, Linda Mileshkin, David Ball, Michael Michael, Angela Burman, Preethi Mayura-Guru, Joseph A Trapani, Stefan Peinert, Dirk Honemann, H Miles Prince, Andrew M Scott, Mark J Smyth, Phillip K Darcy, Michael H Kershaw

Journal article  |  2009  |  Journal of Immunotherapy

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator

KE Herbert, S Morgan, HM Prince, DA Westerman, MM Wolf, DA Carney, K Yuen, J di Iulio, JF Seymour

Journal article  |  2009  |  Leukemia

Clinical and Immunohistochemical Features Associated with a Response to Bortezomib in Patients with Multiple Myeloma

Mark A Dawson, Stephen S Opat, Yamna Taouk, Mark Donovan, Michele Zammit, Katherine Monaghan, Noemi Horvath, Andrew W Roberts, H Miles Prince, Mark Hertzberg, Catriona A McLean, Andrew Spencer

Journal article  |  2009  |  Clinical Cancer Research

Predicting durable remissions following thalidomide therapy for relapsed myeloma

Hang Quach, Linda Mileshkin, John F Seymour, Alvin Milner, David Ritchie, Simon Harrison, David Westerman, H Miles Prince

Journal article  |  2009  |  Leukemia and Lymphoma

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program

Joseph R Mikhael, Andrew R Belch, H Miles Prince, Maria Nambo Lucio, Angelo Maiolino, Alessandro Corso, Maria Teresa Petrucci, Pellegrino Musto, Mieczyslaw Komarnicki, A Keith Stewart

Journal article  |  2009  |  British Journal of Haematology

Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma

Stefan Peinert, Sarah Kamel, John F Seymour, H Miles Prince

Journal article  |  2009  |  Leukemia and Lymphoma

IgA nephropathy associated with cutaneous T cell lymphoma

Ashish Bajel, Ming Yin Lin, Prudence A Hill, David Goodman, Chris McCormack, Peter Foley, Jill Davison, Dirk Hoenemann, Melita Kenealy, Stephen Lade, Gail Ryan, Henry Miles Prince

Journal article  |  2009  |  Leukemia & Lymphoma

Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set

MJ Bishton, RJ Hicks, HM Prince, DS Ritchie, M Wolf, JF Seymour

Journal article  |  2008  |  Leukemia

A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma

MG Bernengo, F Vanaclocha, M Duvic, T Kuzel, F Kerdel, L Pinter-Brown, A Bosly, C Okada, D Breneman, PL Zinzani, J Becker, L Hughey, M Ardaiz, J Zain, L Zhang, S Hirawat, G Laird, D Johnson, HM Prince

Conference Proceedings  |  2008  |  Haematologica Meeting Reports

Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation

Suzanne O Arulogun, H Miles Prince, Jonathan Ng, Stephen Lade, Gail F Ryan, Odette Blewitt, Christopher McCormack

Journal article  |  2008  |  Blood

Extracorporeal photopheresis for the treatment of Sezary syndrome using a novel treatment protocol

Suzanne Arulogun, H Miles Prince, Peter Gambell, Stephen Lade, Gail Ryan, Eve Eaton, Christopher McCormack

Journal article  |  2008  |  Journal of the American Academy of Dermatology

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

Mary ED Flowers, Jane F Apperley, Koen van Besien, Ahmet Elmaagacli, Andrew Grigg, Vijay Reddy, Andrea Bacigalupo, Hans-Jochem Kolb, Luis Bouzas, Mauricette Michallet, H Miles Prince, Robert Knobler, Dennis Parenti, Jose Gallo, Hildegard T Greinix

Journal article  |  2008  |  Blood

Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients

Saar Gill, Steven W Lane, Julie Crawford, Gavin Cull, David Joske, Paula Marlton, Peter N Mollee, H Miles Prince, John F Seymour

Journal article  |  2008  |  Annals of Hematology

Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma

Leigh Ellis, Yan Pan, Gordon K Smyth, Daniel J George, Chris McCormack, Roxanne Williams-Truax, Monica Mita, Joachim Beck, Howard Burris, Gail Ryan, Peter Atadja, Dale Butterfoss, Margaret Dugan, Kenneth Culver, Ricky W Johnstone, H Miles Prince

Journal article  |  2008  |  Clinical Cancer Research

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice

JA Westwood, WK Murray, M Trivett, A Shin, P Neeson, DP MacGregor, NM Haynes, JA Trapani, P Mayura-Guru, S Fox, S Peinert, D Honemann, HM Prince, D Ritchie, AM Scott, FE Smyth, MJ Smyth, PK Darcy, MH Kershaw

Journal article  |  2008  |  Gene Therapy

The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization

Kirsten E Herbert, Jean-Pierre Levesque, David N Haylock, Miles Princes

Journal article  |  2008  |  Biology of Blood and Marrow Transplantation

[F-18] fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma

Saar Gill, Max Wolf, H Miles Prince, Henry Januszewicz, David Ritchie, Rodney J Hicks, John F Seymour

Journal article  |  2008  |  Clinical Lymphoma & Myeloma

A prospective study of the separate predictive capabilities of (18)[F]-FDG-PET and molecular response in patients with relapsed indolent nonHodgkin's lymphoma following treatment with iodine-(131)-rituximab radio-immunotherapy

Mark J Bishton, Rodney J Hicks, David A Westerman, Miles H Prince, Max Wolf, John F Seymour

Journal article  |  2008  |  Haematologica

The development of novel immunotherapeutic approaches in multiple myeloma

Stefan Peinert, H Miles Prince, Simon Harrison

Journal article  |  2008  |  Leukemia & Lymphoma

Histone deacetylase inhibitors in lymphoma and solid malignancies

Walid Rasheed, Mark Bishton, Ricky W Johnstone, H Miles Prince

Journal article  |  2008  |  Expert Review of Anticancer Therapy

Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade

Jayne S Sutherland, Lisa Spyroglou, Jennifer L Muirhead, Tracy S Heng, Adria Prieto-Hinojosa, H Miles Prince, Ann P Chidgeyl, Anthony P Schwarer, Richard L Boyd

Journal article  |  2008  |  Clinical Cancer Research

In vivo tracking of dendritic cells in patients with multiple myeloma

H Miles Prince, Dominic M Wall, David Ritchie, Dirk Honemann, Simon Harrrison, Hang Quach, Mick Thompson, Rodney Hicks, Eddie Lau, Jill Davison, Maureen Loudovaris, Jude Moloney, Bruce Loveland, Jacques Bartholeyns, Andrew Katsifis, Linda Mileshkin

Journal article  |  2008  |  Journal of Immunotherapy

Clinically relevant QTc prolongation is not associated with current dose schedules of LBH589 (panobinostat)

Lei Zhang, David Lebwohl, Eric Masson, Glen Laird, Michael R Cooper, H Miles Prince

Journal article  |  2008  |  Journal of Clinical Oncology

Successful treatment of Behcet's disease with lenalidomide

J Green, E Upjohn, C McCormack, J Zeldis, HM Prince

Journal article  |  2008  |  British Journal of Dermatology

The potential of histone deacetylase inhibitors for the treatment of multiple myeloma

H Miles Prince, Mark Bishton, Simon Harrison

Journal article  |  2008  |  Leukemia & Lymphoma

Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients

Nadege Bercovici, Nacilla Haicheur, Severine Massicard, Fredcrique Vernel-Pauillac, Olivier Adotevi, Didier Landais, Isabelle Gorin, Caroline Robert, H Miles Prince, Jean-Jacques Grob, Marie Therese Leccia, Thierry Lesimple, John Wijdenes, Jacques Bartholeyns, Wolf H Fridman, Margarita Salcedo, Estelle Ferries, Eric Tartour

Journal article  |  2008  |  Journal of Immunotherapy

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

Meletios Dimopoulos, Andrew Spencer, Michael Attal, H Miles Prince, Jean-Luc Harousseau, Anna Dmoszynska, Jesus San Miguel, Andrzej Hellmann, Thierry Facon, Robin Foa, Alessandro Corso, Zvenyslava Masliak, Marta Olesnyckyj, Zhinuan Yu, John Patin, Jerome B Zeldis, Robert D Knight

Journal article  |  2007  |  New England Journal of Medicine

Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma

Saar Gill, Jeremy Shapiro, David Westerman, H Miles Prince

Journal article  |  2007  |  Journal of Clinical Oncology

Epigenetic targets in hematological malignancies: Combination therapies with HDACis and demethylating agents

Mark Bishton, Melita Kenealy, Ricky Johnstone, Walid Rasheed, H Miles Prince

Journal article  |  2007  |  Expert Review of Anticancer Therapy

Safety and efficacy of combining ATRA with G-CSF in HSPC mobilization; a pilot study in multiple myeloma and non-Hodgkin's lymphoma patients

KE Herbert, S True, G McArthur, HM Prince

Journal article  |  2007  |  Bone Marrow Transplantation

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study

S Feyler, HM Prince, R Pearce, K Towlson, I Nivison-Smith, S Schey, J Gibson, N Patton, K Bradstock, DI Marks, G Cook

Journal article  |  2007  |  Bone Marrow Transplantation